Abstract

There are multiple treatment options for depression, anxiety, psychosis, and other psychiatric disorders, and psychiatry patients are often comorbid with complex, polypharmacy treatment regimens. Unlike cardiovascular disease and diabetes, there are no readily available biomarkers to gauge treatment and success with psychotropic medications, often resulting in subjective determination of medication therapy effectiveness.

Read the full article